Is a Start-up Right for You?
Tuesday, March 19 @ 5:30 pm - 7:30 pm
Join us in speaking with CEOs and employees of local start-ups and larger companies to hear how they came to their decision of joining or not joining the start-up world in different phases of their lives. Our panelists have experience working for or founding a start-up as well as have experience working for larger corporations. They will discuss the factors considered while making their career path transitions in and out of start-ups: company stage, culture, team organization, technologies, and personal preferences. In turn, you will learn what signs to look for when assessing whether or not to make the start-up move!
This event is for you if:
- You are interested in working for a start-up
- You are working for a start-up and want to broaden your perspective
- You are working in a larger company but want to function as a start-up
- Janice Kranz: President and CEO, Eikonizo Therapeutics, Inc.
- Anh Hoang: Co-Founder & Chief Scientific Officer, Sofregen Medical
- Madlene Dole: Head of Clinical Quality, Novartis Institutes for Biomedical Research (NIBR)
- Lynnelle Pittet: Senior Director, Alliance & Program Management, Wave Life Sciences
Early Bird Registration
(ENDS March 16th)
MASS AWIS members $10 · Non-members $20
MASS AWIS members $15 · Non-members $30
Janice Kranz is the President and CEO of Eikonizo Therapeutics, Inc., a startup biotech in LabCentral focused on Alzheimer’s drug discovery that she co-founded in 2017 with colleagues from the MGH Martinos Imaging Center. Jan holds a BS in Chemistry from the University of Illinois and a PhD in Biology from Harvard. After receiving her PhD, she was one of the first scientists at Cubist Pharmaceuticals. Being bitten by the ‘startup bug’, she continued to pursue similar opportunities in different settings: a startup company focused on scientific databases (Proteome), a non-profit ALS Therapy Development Institute, and the Broad Institute, where she worked with Ed Scolnick to create and build the Stanley Center for Psychiatric Research. Until founding Eikonizo, Jan was an independent consultant helping startup biotech companies with project management and grant strategy. In her free time, one of her favorite pastimes is hiking with her husband and dogs.
Anh is a co-founder and Chief Science Officer of Sofregen Medical, an early commercial stage company focused on leveraging silk protein to develop products to empower physicians to not just treat but to restore soft tissue volume defects. Under her leadership, the company received two FDA clearances fro the use of silk in soft tissue support — including the first FDA cleared project made from reconstituted silk protein, pioneered at Tufts University, to restore phonation to the vocal fold. Sofregen is currently working to expand their pipeline into medical aesthetic to include a tissue filler with the promise of regenerating lost tissue volume associated with aging.
Prior to Sofregen, Anh was a research fellow at Harvard Medical School where they worked to develop an on-chip platform for the detection and molecular probing of infectious diseases and breast cancer. She received her PhD in Materials Sciences from Vanderbilt University. Outside of work, Anh is a lecturer for the Biomedical Engineering Department at Tufts University, serves on the Massachusetts Biotechnology Council’s Medical Device Advisory Board, serves on the leadership board at Mount Holyoke College, and is a recipient of the 2018 Medtech Boston 40 under 40 Healthcare Innovator award.
Madlene Dole is the Head of Clinical Quality for the Novartis Institutes for Biomedical Research (NIBR). Madlene has been in the Pharmaceutical Industry for 15+ years and has developed broad experience covering various areas of the business including IT, Supply Chain, Chemical Manufacturing, and Program Management. Madlene has also developed and led the holistic cross-functional Data Integrity Program for Novartis. She has extensive experience driving quality culture, as well as organizational and process improvements and is passionate about bringing scientific and clinical innovation to patients.
Madlene holds a Master’s degree in Pharmacology from Duke University and is a Swiss-American dual citizen. She is married with two children and is currently training for the Boston Marathon (her first) to raise money for research at the Dana-Farber Cancer Institute.
Lynnelle Pittet is currently Senior Director, Alliance and Program Management at Wave Life Sciences, where she is responsible for leading and developing the Alliance Management function. She is the alliance manager for Wave’s collaborations with Pfizer (hepatic diseases), Takeda (neurological diseases), and Deep Genomics (artificial intelligence to identify novel therapies for neuromuscular diseases). Lynnelle is passionate about working with others to develop novel drugs and treatments for patients.
Previously, Lynnelle worked at Cerulean Pharma as Director of Program and Alliance Management, Epizyme as Senior Manager of Alliance and Program Management, and Selecta Biosciences as a Senior Scientist. In addition, Lynnelle taught at Simmons College, Harvard University, and Montana State University.
Lynnelle has a PhD in Veterinary Molecular Biology (now Microbiology and Immunology) from Montana State University, a MBA from Simmons College, and a BA in Biology (minor in Chemistry) from Whitman College. She completed her postdoctoral fellowship at Harvard School of Public Health and Boston University School of Medicine. Lynnelle has been an active AWIS member since 2007. She has participated in the MASS AWIS mentoring program as both a mentee and a mentor. She was co-chair of the MASS AWIS Events Committee in 2010 and Vice President of the chapter in 2011.
MASS AWIS is the Massachusetts Chapter of the National Association for Women in Sciences. Our mission is to support women in all scientific fields and to achieve equity and full participation for women in science, mathematics, engineering, and technology. Our events and membership are open for the public regardless of their gender, professional background, or career level.